Current advances in the management of malignant germ cell and sex cord-stromal tumors of the ovary

Gynecologic Oncology

Volumn 125, Issue 3, 2012, Pages 515-517

  Gershenson, David M ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURGERY; DISEASE SURVEILLANCE; HUMAN; LONG TERM CARE; MALIGNANT OVARIAN GERM CELL TUMOR; MOLECULAR BIOLOGY; NOTE; OVARIAN SEX CORD STROMAL TUMOR; OVARY CANCER; PRIORITY JOURNAL; SEX CORD TUMOR;

EID: 84861200804     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.03.019     Document Type: Editorial

References (25)

1. H.O. Smith, M. Berwick, C.F. Verschraegen, C. Wiggins, L. Lansing, and C.Y. Muller Incidence and survival rates for female malignant germ cell tumors Obstet Gynecol 107 5 2006 1075 1085
2. S. Schumer, and S.A. Cannistra Granulosa cell tumor of the ovary J Clin Oncol 21 6 2003 1180 1189
3. R.D. Palmer, M.J. Murray, H.K. Saini, S. van Dongen, C. Abreu-Goodger, and B. Muralidhar Malignant germ cell tumors display common microRNA profiling resulting in global changes in expression of messenger RNA targets Cancer Res 70 7 2010 2911 2923
4. M.J. Murray, D.J. Halsall, C.E. Hook, D.M. Williams, J.C. Nicholson, and N. Coleman Identification of microRNAs from the miR-371-373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors Am J Clin Pathol 135 1 2011 119 125
5. L. Cheng, L.M. Roth, S. Zhang, M. Wang, M.J. Morton, and W. Zheng KIT gene mutation and amplification in dysgerminoma of the ovary Cancer 117 10 2011 2096 2103
6. G. Mangili, C. Sigismondi, A. Gadducci, G. Cormio, P. Scollo, and S. Tateo Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-o retrospective study Int J Gynecol Cancer 21 8 2011 1414 1421
7. D.M. Gershenson Management of ovarian germ cell tumors J Clin Oncol 25 10 2007 2938 2943
8. D. Billmire, C. Vinocur, F. Rescorla, B. Cushing, W. London, and M. Schlatter Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study J Pediatr Surg 39 3 2004 424 429
9. G. Mangili, C. Sigismondi, D. Lorusso, G. Cormio, P. Scollo, and R. Viganò Is surgical restaging indicated in apparent stage IA pure ovarian dysgerminoma? The MITO group retrospective experience Gynecol Oncol 121 2 2011 280 284
10. C. Bonazzi, F. Peccatori, N. Colombo, V. Lucchini, M.G. Cantu, and C. Mangioni Pure ovarian immature teratoma, a unique and curable disease: 10 years' experience of 32 prospectively treated patients Obstet Gynecol 84 4 1994 598 604
11. G.G. Dark, M. Bower, E.S. Newlands, F. Paradinas, and G.J. Rustin Surveillance policy for stage I ovarian germ cell tumors J Clin Oncol 15 2 1997 620 624
12. P.L. Mitchell, N. Al-Nasiri, R. A'Hern, C. Fisher, A. Horwich, and C.R. Pinkerton Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases Cancer 85 10 1999 2232 2244
13. B. Cushing, R. Giller, A. Ablin, L. Cohen, J. Cullen, and E. Hawkins Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the Pediatric Oncology Group and the Children's Cancer Group Am J Obstet Gynecol 181 2 1999 353 358
14. N.M. Marina, B. Cushing, R. Giller, L. Cohen, S.J. Lauer, and A. Ablin Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: a Pediatric Oncology Group/Children's Cancer Group Intergroup study J Clin Oncol 17 7 1999 2137 2143
15. U. Göbel, D.T. Schneider, G. Calaminus, R.J. Haas, P. Schmidt, and D. Harms Germ-cell tumors in childhood and adolescence: GPOH MAKEI and the MAHO study groups Ann Oncol 11 3 2000 263 271
16. S.P. Shah, M. Köbel, J. Senz, R.D. Morin, B.A. Clarke, and K.C. Wiegand Mutation of FOXL2 in granulosa-cell tumors of the ovary N Engl J Med 360 26 2009 2719 2729
17. O.M. Al-Agha, H.F. Huwait, C. Chow, W. Yang, J. Senz, and S.E. Kalloger FOXL2 is a sensitive and specific marker for ses cord-stromal tumors of the ovary Am J Surg Pathol 35 4 2011 484 494
18. M. Köbel, C.B. Gilks, and D.G. Huntsman Adult-type granulosa cell tumors and FOXL2 mutation Cancer Res 69 24 2009 9160 9162
19. K.A. Schultz, M.C. Pacheco, J. Yang, G.M. Williams, Y. Messinger, and D.A. Hill Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry Gynecol Oncol 122 2 2011 246 250
20. A. Heravi-Moussavi, M.S. Anglesio, S.W. Cheng, J. Senz, W. Yang, and L. Prentice Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers N Engl J Med 366 3 2012 234 242
21. M.M. Thrall, P. Paley, E. Pizer, R. Garcia, and B.A. Goff Patterns of spread and recurrence of sex cord-stromal tumors of the ovary Gynecol Oncol 122 2 2011 242 245
22. N.R. Abu-Rustum, A. Restivo, J. Ivy, R. Soslow, P. Sabbatini, and Y. Sonoda Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary Gynecol Oncol 103 1 2006 31 34
23. J. Brown, A.K. Sood, M.T. Deavers, L. Milojevic, and D.M. Gershenson Patterns of metastasis in sex cord-stromal tumors of the ovary: can routine staging lymphadenectomy be omitted? Gynecol Oncol 113 1 2009 86 90
24. E. Volpi, A. Ferrero, E. Cassina, and F. Pastorino Laparoscopic restaging of ovarian granulosa cell tumor: three cases report Gynecol Surg 6 2009 77 81
25. X. Tao, A.K. Sood, M.T. Deavers, K.M. Schmeler, A.M. Nick, and R.L. Coleman Anti-angiogenesis therapy with bevacizumab for patients with ovarian granulosa cell tumors Gynecol Oncol 114 3 2009 431 436